These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1142 related articles for article (PubMed ID: 23406981)

  • 1. Long-term treatment with citicoline may improve poststroke vascular cognitive impairment.
    Alvarez-Sabín J; Ortega G; Jacas C; Santamarina E; Maisterra O; Ribo M; Molina C; Quintana M; Román GC
    Cerebrovasc Dis; 2013; 35(2):146-54. PubMed ID: 23406981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Citicoline in vascular cognitive impairment and vascular dementia after stroke.
    Alvarez-Sabín J; Román GC
    Stroke; 2011 Jan; 42(1 Suppl):S40-3. PubMed ID: 21164117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Executive function as a strong predictor of recovery from disability in patients with acute stroke: a preliminary study.
    Park YH; Jang JW; Park SY; Wang MJ; Lim JS; Baek MJ; Kim BJ; Han MK; Bae HJ; Ahn S; Kim S
    J Stroke Cerebrovasc Dis; 2015 Mar; 24(3):554-61. PubMed ID: 25534371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term citicoline (cytidine diphosphate choline) use in patients with vascular dementia: neuroimaging and neuropsychological outcomes.
    Cohen RA; Browndyke JN; Moser DJ; Paul RH; Gordon N; Sweet L
    Cerebrovasc Dis; 2003; 16(3):199-204. PubMed ID: 12865605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dementia after Three Months and One Year from Stroke: New Onset or Previous Cognitive Impairment?
    Caratozzolo S; Mombelli G; Riva M; Zanetti M; Gottardi F; Padovani A; Rozzini L
    J Stroke Cerebrovasc Dis; 2016 Nov; 25(11):2735-2745. PubMed ID: 27514578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-Term Treatment with Citicoline Prevents Cognitive Decline and Predicts a Better Quality of Life after a First Ischemic Stroke.
    Alvarez-Sabín J; Santamarina E; Maisterra O; Jacas C; Molina C; Quintana M
    Int J Mol Sci; 2016 Mar; 17(3):390. PubMed ID: 26999113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular cognitive disorders and depression after first-ever stroke: the Fogarty-Mexico Stroke Cohort.
    Arauz A; Rodríguez-Agudelo Y; Sosa AL; Chávez M; Paz F; González M; Coral J; Díaz-Olavarrieta C; Román GC
    Cerebrovasc Dis; 2014; 38(4):284-9. PubMed ID: 25412708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized efficacy trial of citicoline in patients with acute ischemic stroke.
    Clark WM; Williams BJ; Selzer KA; Zweifler RM; Sabounjian LA; Gammans RE
    Stroke; 1999 Dec; 30(12):2592-7. PubMed ID: 10582983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase III randomized efficacy trial of 2000 mg citicoline in acute ischemic stroke patients.
    Clark WM; Wechsler LR; Sabounjian LA; Schwiderski UE;
    Neurology; 2001 Nov; 57(9):1595-602. PubMed ID: 11706098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dl-3-n-butylphthalide can improve the cognitive function of patients with acute ischemic stroke: a prospective intervention study.
    Yan H; Yan Z; Niu X; Wang J; Gui Y; Zhang P
    Neurol Res; 2017 Apr; 39(4):337-343. PubMed ID: 28145815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness and safety of citicoline in mild vascular cognitive impairment: the IDEALE study.
    Cotroneo AM; Castagna A; Putignano S; Lacava R; Fantò F; Monteleone F; Rocca F; Malara A; Gareri P
    Clin Interv Aging; 2013; 8():131-7. PubMed ID: 23403474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of citicoline in cognitive impairment: pharmacological characteristics, possible advantages, and doubts for an old drug with new perspectives.
    Gareri P; Castagna A; Cotroneo AM; Putignano S; De Sarro G; Bruni AC
    Clin Interv Aging; 2015; 10():1421-9. PubMed ID: 26366063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The citicoline brain injury treatment (COBRIT) trial: design and methods.
    Zafonte R; Friedewald WT; Lee SM; Levin B; Diaz-Arrastia R; Ansel B; Eisenberg H; Timmons SD; Temkin N; Novack T; Ricker J; Merchant R; Jallo J
    J Neurotrauma; 2009 Dec; 26(12):2207-16. PubMed ID: 19803786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral citicoline in acute ischemic stroke: an individual patient data pooling analysis of clinical trials.
    Dávalos A; Castillo J; Alvarez-Sabín J; Secades JJ; Mercadal J; López S; Cobo E; Warach S; Sherman D; Clark WM; Lozano R
    Stroke; 2002 Dec; 33(12):2850-7. PubMed ID: 12468781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Citicoline in the treatment of acute ischaemic stroke: an international, randomised, multicentre, placebo-controlled study (ICTUS trial).
    Dávalos A; Alvarez-Sabín J; Castillo J; Díez-Tejedor E; Ferro J; Martínez-Vila E; Serena J; Segura T; Cruz VT; Masjuan J; Cobo E; Secades JJ;
    Lancet; 2012 Jul; 380(9839):349-57. PubMed ID: 22691567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mortality and institutionalization in early survivors of stroke: the effects of cognition, vascular mild cognitive impairment, and vascular dementia.
    Brodaty H; Altendorf A; Withall A; Sachdev PS
    J Stroke Cerebrovasc Dis; 2010; 19(6):485-93. PubMed ID: 20538487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of citicoline on functional and cognitive status among patients with traumatic brain injury: Citicoline Brain Injury Treatment Trial (COBRIT).
    Zafonte RD; Bagiella E; Ansel BM; Novack TA; Friedewald WT; Hesdorffer DC; Timmons SD; Jallo J; Eisenberg H; Hart T; Ricker JH; Diaz-Arrastia R; Merchant RE; Temkin NR; Melton S; Dikmen SS
    JAMA; 2012 Nov; 308(19):1993-2000. PubMed ID: 23168823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Open-label pilot clinical trial of citicoline for fragile X-associated tremor/ataxia syndrome (FXTAS).
    Hall DA; Robertson EE; Leehey M; McAsey A; Ouyang B; Berry-Kravis E; O'Keefe JA
    PLoS One; 2020; 15(2):e0225191. PubMed ID: 32053612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrolysin in vascular dementia: improvement of clinical outcome in a randomized, double-blind, placebo-controlled multicenter trial.
    Guekht AB; Moessler H; Novak PH; Gusev EI;
    J Stroke Cerebrovasc Dis; 2011; 20(4):310-8. PubMed ID: 20656516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic value of domain-specific cognitive abilities in acute first-ever stroke.
    Nys GM; van Zandvoort MJ; de Kort PL; van der Worp HB; Jansen BP; Algra A; de Haan EH; Kappelle LJ
    Neurology; 2005 Mar; 64(5):821-7. PubMed ID: 15753416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 58.